Docmode Health Technologies Ltd
Incorporated in 2017, Doctrack Solutions Ltd is engaged in the business of offering integrated learning solutions through online and offline learning models to healthcare professionals and learners.[1]
- Market Cap ₹ 6.91 Cr.
- Current Price ₹ 22.0
- High / Low ₹ 125 / 22.0
- Stock P/E
- Book Value ₹ 26.2
- Dividend Yield 0.00 %
- ROCE 6.12 %
- ROE -1.57 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.84 times its book value
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 29.5%
- Company has a low return on equity of -8.01% over last 3 years.
- Promoters have pledged 37.4% of their holding.
- Earnings include an other income of Rs.1.39 Cr.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Consumer Services Other Consumer Services E-Learning
Part of Nifty SME Emerge
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 6.94 | 7.09 | 12.42 | 32.88 | 39.93 | 41.71 | 25.40 | |
| 6.55 | 6.22 | 10.52 | 29.14 | 38.05 | 42.40 | 25.73 | |
| Operating Profit | 0.39 | 0.87 | 1.90 | 3.74 | 1.88 | -0.69 | -0.33 |
| OPM % | 5.62% | 12.27% | 15.30% | 11.37% | 4.71% | -1.65% | -1.30% |
| 0.00 | 0.00 | 0.01 | 0.10 | 0.14 | 0.93 | 1.39 | |
| Interest | 0.01 | 0.19 | 0.38 | 1.13 | 1.65 | 1.91 | 0.97 |
| Depreciation | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | 0.30 | 0.23 |
| Profit before tax | 0.33 | 0.64 | 1.51 | 2.69 | 0.35 | -1.97 | -0.14 |
| Tax % | -6.06% | 14.06% | 38.41% | 27.88% | 42.86% | 3.05% | -7.14% |
| 0.34 | 0.55 | 0.92 | 1.95 | 0.19 | -2.03 | -0.13 | |
| EPS in Rs | 8.50 | 0.60 | -6.46 | -0.41 | |||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 29% |
| 3 Years: | -8% |
| TTM: | -39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 94% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -81% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | -8% |
| Last Year: | -2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.01 | 2.29 | 3.14 | 3.14 | 3.14 |
| Reserves | -0.10 | 0.46 | 1.38 | 1.19 | 7.24 | 5.21 | 5.08 |
| 0.02 | 1.06 | 4.84 | 8.48 | 9.18 | 6.82 | 3.73 | |
| 1.96 | 4.14 | 3.86 | 5.05 | 10.62 | 24.14 | 21.55 | |
| Total Liabilities | 1.89 | 5.67 | 10.09 | 17.01 | 30.18 | 39.31 | 33.50 |
| 0.05 | 0.03 | 0.06 | 0.05 | 0.97 | 1.22 | 0.98 | |
| CWIP | 0.10 | 0.12 | 0.44 | 2.03 | 8.50 | 11.60 | 13.48 |
| Investments | 0.00 | 0.10 | 1.25 | 1.20 | 1.26 | 1.29 | 1.31 |
| 1.74 | 5.42 | 8.34 | 13.73 | 19.45 | 25.20 | 17.73 | |
| Total Assets | 1.89 | 5.67 | 10.09 | 17.01 | 30.18 | 39.31 | 33.50 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 0.17 | -0.50 | -2.05 | -0.83 | 4.49 | 6.64 | 4.35 | |
| -0.20 | -0.13 | -1.52 | -1.57 | -7.55 | -3.67 | -1.89 | |
| 0.01 | 0.84 | 3.41 | 2.65 | 5.76 | -4.27 | -4.06 | |
| Net Cash Flow | -0.03 | 0.21 | -0.17 | 0.25 | 2.70 | -1.30 | -1.61 |
| Free Cash Flow | -0.03 | -0.54 | -2.42 | -2.43 | -2.93 | 2.99 | 2.47 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 46% | -57% | -103% | -22% | 238% | -981% | -1,318% |
Ratios
Standalone / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 0.53 | 70.01 | 112.26 | 92.03 | 104.85 | 80.86 | 106.91 |
| Inventory Days | 120.77 | 668.83 | 588.71 | 822.31 | |||
| Days Payable | 60.38 | 511.82 | 379.13 | 372.43 | |||
| Cash Conversion Cycle | 60.91 | 227.03 | 321.84 | 92.03 | 104.85 | 80.86 | 556.80 |
| Working Capital Days | -22.62 | 30.37 | 92.28 | 50.07 | 11.06 | -54.26 | -95.85 |
| ROCE % | 113.70% | 48.71% | 42.00% | 12.69% | -0.35% | 6.12% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Employee Count employees |
|
|||
| DocMode SURE Registered HCPs HCPs |
||||
| AIDE Active Users users |
||||
| Certification Programs courses |
||||
| DocMode LERN Registered HCPs HCPs |
||||
| National & International Speaker Programs programs |
||||
Extracted by Screener AI
Documents
Announcements
-
Updates
- Board approved FY26 audited standalone/consolidated results on 4 Sep 2026; auditors issued qualified opinion over NCD default.
-
Updates
- Submitted share capital reconciliation audit report for quarter ended 30 September 2026.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Submitted Regulation 74(5) certificate for quarter ended 30 September 2026; no rematerialisation requests.
-
Updates
- Company intimates receipt of SEBI SAST disclosure from Ramesh Kumar Jain and Ramesh Jain HUF.
-
Updates
- Company received SAST disclosure from Ramesh Kumar Jain and HUF under Regulation 29.
Annual reports
-
Annual Report 2026
from nse
-
Annual Report 2025
from nse
-
Annual Report 2024
from nse
Business Overview:[1]
DSL offers integrated learning solutions—online and offline—to healthcare professionals and learners globally, spanning the education value chain. It also operates a network-powered surveys and research offering, enabling healthcare professionals to participate in marketing surveys and clinical studies; a knowledge marketing services line supporting medico-marketing organisations with promotional literature, medical writing, and customised learning; clinical research support under an Ethics Committee registered with CDSCO; and an online store offering books, journals, event passes, and memberships for healthcare professionals.